At a glance
- Originator Helopharm
- Developer Boehringer Ingelheim; Helopharm
- Class Class Ic antiarrhythmics; Propiophenones; Small molecules
- Mechanism of Action Beta-adrenergic receptor antagonists; Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.